US FDA premarket approval of tDCS depression treatment is not yet scientifically justified

Jana Klaus; Fenne M Smits; André Aleman; Chris Baeken; Philip van Eijndhoven; Odile A van den Heuvel; Dennis J L G Schutter

doi:10.1016/S2215-0366(26)00092-1

US FDA premarket approval of tDCS depression treatment is not yet scientifically justified

Jana Klaus
, Fenne M Smits
, André Aleman
, Chris Baeken
, Philip van Eijndhoven
, Odile A van den Heuvel
, Dennis J L G Schutter

Psychiatry

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

Original language	English
Pages (from-to)	726-728
Number of pages	3
Journal	The Lancet. Psychiatry
Volume	13
Issue number	9
Early online date	16 Apr 2026
DOIs	https://doi.org/10.1016/S2215-0366(26)00092-1
Publication status	Published - Sept 2026

Access to Document

10.1016/S2215-0366(26)00092-1

Cite this

@article{cb62b999b4a44077a4beec4ef507f9d5,

title = "US FDA premarket approval of tDCS depression treatment is not yet scientifically justified",

author = "Jana Klaus and Smits, \{Fenne M\} and Andr{\'e} Aleman and Chris Baeken and \{van Eijndhoven\}, Philip and \{van den Heuvel\}, \{Odile A\} and Schutter, \{Dennis J L G\}",

year = "2026",

month = sep,

doi = "10.1016/S2215-0366(26)00092-1",

language = "English",

volume = "13",

pages = "726--728",

journal = "The Lancet. Psychiatry",

issn = "2215-0366",

publisher = "Elsevier Limited",

number = "9",

}

TY - JOUR

T1 - US FDA premarket approval of tDCS depression treatment is not yet scientifically justified

AU - Klaus, Jana

AU - Smits, Fenne M

AU - Aleman, André

AU - Baeken, Chris

AU - van Eijndhoven, Philip

AU - van den Heuvel, Odile A

AU - Schutter, Dennis J L G

PY - 2026/9

Y1 - 2026/9

UR - https://www.scopus.com/pages/publications/105044133731

U2 - 10.1016/S2215-0366(26)00092-1

DO - 10.1016/S2215-0366(26)00092-1

M3 - Comment/Letter to the editor

C2 - 42001875

SN - 2215-0366

VL - 13

SP - 726

EP - 728

JO - The Lancet. Psychiatry

JF - The Lancet. Psychiatry

IS - 9

ER -

US FDA premarket approval of tDCS depression treatment is not yet scientifically justified

Access to Document

Other files and links

Embargoed Document

Cite this